Parameter |
SHS-PWD EO-PE (N=56) |
SHS-PWD LO-PE (N=97) |
SHS-PWD NTN-PW
(N=95) |
p-value |
OHS-PWD EO-PE (N=14) |
OHS-PWD LO-PE (N=30) |
OHS-PWD NTN-PW (N=206) |
p-value |
Nulliparous |
38(67.9) * |
24(24.7) * |
26(27.4) † |
<0.0001 |
9(64.3) ǂ |
8(26.7) ǂ |
3(1.5) |
<0.001 |
Family history of HTN |
14(25.0) *¥ |
18(18.6) *‡ |
8(12.6) † |
0.0197 |
6(42.9) ǂ |
9(30.0) ǂ |
4(1.9) |
<0.001 |
History of miscarriage |
18(32.1) * |
12(12.3) * |
3(3.2) † |
<0.001 |
3(21.4) ǂ |
6(20.0) ǂ |
2(0.9) |
<0.001 |
Previous caesarean section |
22(39.2) * |
15(15.5) * |
8(8.4) † |
<0.001 |
5(35.7) ǂ |
3(10.0) ǂ |
5(2.4) |
<0.001 |
Preterm delivery |
39(69.6) * |
20(20.6) *‡ |
5(5.3) † |
<0.001 |
8(57.1) ǂ |
15(50.0) ǂ |
8(3.9) |
<0.001 |
Low monthly income |
27(48.2) * |
13(13.4) * |
6(6.3) † |
<0.001 |
7(50.0) ǂ |
5(16.7) ǂ |
28(13.6) |
0.0015 |
Maternal age (years) |
34.0(21.8-38.8) * ¥ |
28(24-33) * |
30.0(27.0-34.0) |
<0.001 |
29.0(26.0-33.0) |
28.5(22-33.5) |
30.0(26.0-34.0) |
0.0731 |
SBP (mmHg) |
180.0(168-189.0) * |
160.0(156.0-180.0) *‡ |
120.0(114.0-122.0) † |
<0.001 |
164.0(160.0-184.0) ǂ |
148.0(159.0-173.0) ǂ |
116.0(114.0-121.0) |
<0.001 |
DBP (mmHg) |
105.0(100-113.0) * |
104.0(100.0-110.0) * |
78.0(70.0-80.0) |
<0.001 |
103.0(100.0-113.0) ǂ |
101.0(100.0-110.0)
ǂ |
76.0(69.0-80.0) |
<0.001 |
GA at delivery |
32.0(32.0-33.0) * |
37.0(35.0-38.0) * |
38.0(37.0-39.0) |
<0.001 |
33.0(32.8-33) ǂ |
36.0(34.0-37.0) ǂ |
38.0(37.0-39.0) |
<0.001 |
Serum PlGF (pg/ml) |
71.5(45.2-95.2) * |
73.8(42.4-95.6) * |
104.6(97.5-109.9) |
<0.001 |
90.1(62.2-102) ǂ |
83.3(51.4-96.9) ǂ |
103.5(96.8-110.1) |
<0.001 |
Serum VEGF-A (pg/ml) |
114.1(71.2-137.1) |
110.8(82.4-172.2) * |
200.6
(182-212) |
<0.001 |
143.1(93.0-186.1) ǂ |
126.7(110.5-189.2) ǂ |
203.4 (182.0-232.0) |
<0.001 |
Serum sEng (ng/mL) |
11.9(10.5-14.3) * |
10.7(8.9-13.5) * |
8.7(7.8-9.9) |
<0.001 |
11.3(9.0-13.9) ǂ |
10.1(7.7-12.9) ǂ |
8.5(7.6-10.2) |
<0.001 |
Serum sFlt-1 (pg/ml) |
1290(898.1-1581) * |
1107(837-1389) * |
787.5(623.9-980) |
<0.001 |
1142(796-1358) ǂ |
886(727-1082) ǂ |
761.1(623-950) |
<0.001 |
Serum 8-epiPGF2α (pg/ml) |
2560(2057-3115) * |
2187(1599-2882) * |
1472
(1185-1894) |
<0.001 |
2223(1489-2636) ǂ |
1625(1428-675.8) ǂ |
1466(1215-1839) |
<0.001 |
Urinary 8-OHdG (ng/mg Cr) |
281.1(249.5-312.3) * |
259.3(235.7-296.2) * |
178.4(127.4-251.9) |
<0.001 |
258.7(251.1-303.4) ǂ |
255.3(234.8-261.2) ǂ |
176.5(135.1-238.8) |
<0.001 |
Serum 8-OHdG (ng/L) |
142.6(131.6-155.7) * |
136.1(124.0-151.2) * |
118.4(79.2-133.2) |
<0.001 |
136.4(132.2-151.4) ǂ |
132.1(115.6-141.9) ǂ |
114.5(82.3-132.0) |
<0.001 |
Plasma TAC (µmol/l) |
131.4(109.9-192.3) * |
180.9(119.9-249.5) * |
373.8(268.5-472.9) |
<0.001 |
160.9(112.4-225.2) ǂ |
199.6(118.8-243.4) ǂ |
351.6(261.9-475.8) |
<0.001 |
sFlt-1: PlGF ratio |
17.5(11.8-31.1) * |
15.0(11.0-23.5) * |
7.4(5.7-9.5) |
<0.001 |
11.9(8.2-14.0) ǂ |
12.9(9.5-18.3) ǂ |
6.7(5.4-9.3) |
<0.001 |
8-epiPGF2alpha: PlGF ratio |
34.4(26.1-64.8) * |
29.5(20.8-48.6) * |
14.7(11.3-18.7) |
<0.001 |
21.8(15.0-26.7) ǂ |
24.7(15.6-35.8) ǂ |
13.4(10.4-17.8) |
<0.001 |
8-OHdG: PlGF ratio |
1.9(1.4-3.5) * |
1.5(1.2-2.9) * |
1.2(0.7-1.3) |
<0.001 |
1.5(1.2-2.2) ǂ |
1.3(0.8-1.3) ǂ |
1.1(0.7-1.3) |
<0.001 |
sEng: PlGF ratio |
173.2(130.8-287.3) * |
150.5(109.2-257.1) * |
84.6(72.6-101.6) |
<0.001 |
127.8(104.0-173.2) ǂ |
126.4(84.5-181.7) ǂ |
84.1(72.6-100.8) |
<0.001 |